methylprednisolone hemisuccinate has been researched along with Cross Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reinhart, WH | 1 |
| Belenchia, JM; el Torky, M; Estes, RJ; Leeper, KV; Meduri, GU; Wunderink, RG | 1 |
2 other study(ies) available for methylprednisolone hemisuccinate and Cross Infection
| Article | Year |
|---|---|
[An auto-iatrogenic disease].
Topics: Anti-Inflammatory Agents; Atrophy; Cross Infection; Fatal Outcome; Glucocorticoids; Humans; Iatrogenic Disease; Male; Methylprednisolone Hemisuccinate; Middle Aged; Multiple Chemical Sensitivity; Physician Impairment; Prednisone; Pseudomonas Infections; Psychoses, Substance-Induced; Self Medication; Shock, Septic; Substance-Related Disorders | 2004 |
Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids.
Topics: Adult; Biopsy; Cross Infection; Diagnosis, Differential; Female; Fever of Unknown Origin; Humans; Leukocytosis; Lung; Male; Methylprednisolone Hemisuccinate; Pilot Projects; Pneumonia; Pulmonary Fibrosis; Respiratory Distress Syndrome | 1991 |